MIP
PFE icon

Marietta Investment Partners’s Pfizer PFE Stock Holding History

Marietta Investment Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,965
Closed -$332K – 165
2024
Q1 		$332K Sell
11,965
-990
-8% -$27.5K 0.07% 135
2023
Q4 		$373K Sell
12,955
-5,300
-29% -$160K 0.09% 123
2023
Q3 		$606K Hold
18,255
– – 0.17% 101
2023
Q2 		$670K Hold
18,255
– – 0.17% 98
2023
Q1 		$745K Buy
18,255
+2,965
+19% +$128K 0.21% 90
2022
Q4 		$783K Sell
15,290
-200
-1% -$9.59K 0.22% 86
2022
Q3 		$731K Buy
15,490
+780
+5% +$37.9K 0.22% 92
2022
Q2 		$771K Hold
14,710
– – 0.23% 89
2022
Q1 		$762K Hold
14,710
– – 0.17% 101
2021
Q4 		$869K Hold
14,710
– – 0.18% 95
2021
Q3 		$633K Buy
14,710
+210
+1% +$9.3K 0.15% 113
2021
Q2 		$568K Hold
14,500
– – 0.13% 117
2021
Q1 		$525K Sell
14,500
-450
-3% -$16K 0.13% 115
2020
Q4 		$550K Sell
14,950
-1,355
-8% -$49.7K 0.14% 102
2020
Q3 		$568K Buy
16,305
+2,603
+19% +$91.3K 0.17% 91
2020
Q2 		$425K Buy
13,702
+4,216
+44% +$143K 0.14% 95
2020
Q1 		$294K Sell
9,486
-2,912
-23% -$99.2K 0.13% 104
2019
Q4 		$461K Hold
12,398
– – 0.15% 102
2019
Q3 		$423K Hold
12,398
– – 0.15% 102
2019
Q2 		$510K Buy
12,398
+2,740
+28% +$109K 0.17% 95
2019
Q1 		$389K Hold
9,658
– – 0.12% 106
2018
Q4 		$400K Sell
9,658
-2,990
-24% -$124K 0.15% 95
2018
Q3 		$529K Buy
12,648
+3,162
+33% +$122K 0.16% 95
2018
Q2 		$327K Buy
+9,486
New +$324K 0.1% 111
2017
Q1 		– Sell
-9,132
Closed -$281K – 144
2016
Q4 		$281K Buy
9,132
+264
+3% +$8.06K 0.1% 115
2016
Q3 		$285K Sell
8,868
-4,353
-33% -$146K 0.09% 125
2016
Q2 		$442K Buy
+13,221
New +$422K 0.16% 103

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Marietta Investment Partners's PFE Position: Q2 2024 in Review

Marietta Investment Partners sold out of Pfizer (PFE) in Q2 2024, closing a stake of 11,965 shares — an estimated $332K sold.

Marietta Investment Partners first reported a position in PFE in Q2 2016 and held it in 27 quarters. The position peaked at $869K in Q4 2021. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Marietta Investment Partners reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Marietta Investment Partners sold 11,965 Pfizer shares in Q2 2024, an estimated $332K.
  • Marietta Investment Partners first reported a position in Pfizer in Q2 2016 and held it in 27 quarters.
  • Marietta Investment Partners's Pfizer position peaked at $869K in Q4 2021.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Marietta Investment Partners's 13F filing for Q2 2024, filed 14 Aug 2024.